MASTERCLASS
Prof. Xavier Roblin
gastro-entérologue au CHU de Saint-Étienne
Organiser : Pascal Juillerat, MD, MSc
IBD Masterclass 14.06.2017
2
Masterclass
CASE 1
Brindusa Diaconu
3
Masterclass
Mr CS, 7.07.1983
Crohn’s disease, diagnosed 2001 , Montréal A2L4B3
No extraintestinal manifestations
Previous therapies
• Long term Steroids -low dose
• Imurek 50mg daily
• Humira 40mg eow since 2011 –for small intestinal fistulas
• Endoscopic dilation of duodenal stenosis
4
Masterclass
First consultation Inselspital 04/2016
• Acute, self limited diarrhea
• Clinical exam
• H=168cm, Weight=46.5 kg (BMI 16.5)
• No perianal fistulas
5
Masterclass
Lab exams at first consultation
• Low vit D, Hb, Vit B12 and folic acid normal
• TPMT activity 71 (Normal values 35-115)
• 6 TGN : 129 (>235) / 6MMP : 170 (<5000)
[Imurek 50mg daily]
6
Masterclass
Ulcera in the bulbus
7
Masterclass
Relative Stenosis bulbus?pars II and fistula orifices
8
Masterclass
MR Enteroclysis
• In the duodenum and jejunum –segmental thickening of
nondistended bowell walls, partially with enhancement of
the wall-compatible with subacute inflammation
• Increased number and volume of mesenterial lymph nodes
in the left upper abdomen
• No fistulas, no abscesses
9
Masterclass
10
Masterclass
11
Masterclass
Therapeutic options ?
• Continuing the therapy
• Increase of the dosis of Imurek
• Increase of the dosis of Imurek and PPI 2x40mg daily
• Switch from Humira to Infliximab
• Infliximab plus Imurek plus PPI 2x40mg
• Infliximab plus Imurek
12
Masterclass
Answer Prof.Roblin
• Switch from ADA to IFX plus Imurek Plus PPI
(there are some data from GETAID group that suggest that
IFX could be better than ADA for small bowel involvement)
13
Masterclass
Therapy
• Switch from Humira to Infliximab
• PPI 2x40mg daily
• Increase of the dosis of Imurek to 2x50mg daily
14
Masterclass
Evolution
• Abdominal pain
• Vomiting, Diarrhea
• Loss of weight
• No fever, no extraintestinal manifestations
15
Masterclass
Cause of the worsened evolution
16
Masterclass
Cause of the worsened evolution
• Compliance
17
Masterclass
Cause of the worsened evolution
• Compliance
• Acute infection: bacterial, viral
18
Masterclass
Cause of the worsened evolution
• Compliance
• Acute infection: bacterial, viral
• Non response to therapy-trough levels, antibodies against
TNF inhib
19
Masterclass
Cause of the worsened evolution
• Compliance
• Acute infection: bacterial, viral
• Non response to therapy-trough levels, antibodies against
TNF inhib
• Occurence of complications
20
Masterclass
Lab
• CRP=26, L=11.800, Hb 136 →to 125, Alb=18g/L
• Stool cultures negative, Clostridium difficile neg
• Infliximab trough level 2.23 microgr/ml
• Antibodies IFX negativ
Shortening of administration period to 4 weeks
21
Masterclass
ulcers in the esophagus
22
Masterclass
GERD
23
Masterclass
Ulcera in the duodenum
24
Masterclass
Fistula
25
Masterclass
Histology and virology
• Virology and immunhistochemistry- neg for CMV, HSV
• Esophagus- Reflux esophagitis
• Stomach, duodenum- inflammatory changes/no possible
distinction between upper Crohn or peptic disease
26
Masterclass
• Colonoscopy:
• 2-3 aphtoid lesions in the terminal ileum, colon-normal
• MR Enteroclysis -no abscesses or fistulas
27
Masterclass
Therapy
• Enteral nutrition via naso-jejunal tube, later protein drinks
and Modulen
• 3x40mg Pantoprazol for 3 days, for longer time 2x40mg
p.o
• IFX 600mg (10 mg/Kg) every 4 weeks
• Azathioprin 2x50mg
• Substitution iron, Vit D
28
Masterclass
Evolution
• Under IFX 10 mg/kg every 4 weeks – aggravation of
vomiting
29
Masterclass
Questions/discussion
• Inflammatory or fibrotic stenosis in the duodenum?
• Fistula?
30
Masterclass
31
Masterclass
Interdisciplinary discussion
• Ballon dilatation ?
• Temporary stent ?
• Gastro-Enterostomy ?
32
Masterclass
Therapy
• Gastro-enterostomy
• 2 weeks after surgery – restart IFX
• Imurek, Pantoprazol
33
Masterclass
Evolution
• Weight reduction of 2 kg in 3 months
• Vomiting 2 times a week
34
Masterclass
Questions
• New flare ?
• Technical problem with anastomosis?
35
Masterclass
Upper endoscopy
• Duodenal stenosis- acute ulcerations
• Efferent loop –stenotic: passage with nasal endoscope and
blind biopsies
36
Masterclass
Gastro-entero -anastomosis
37
Masterclass
Radiology –evacuation mainly through bulbus, stenosis of efferent
loop
38
Masterclass
Histology
• High inflammatory activity in the duodenum and in the
jejunum, compatible with Crohn s disease
39
Masterclass
Questions-therapy
• Parenteral nutrition plus IFX optimisation according to
trough levels plus Azathioprin ?
• Parenteral nutrition plus IFX plus Azathioprin plus
corticosteroids for short term cortcosteroid treatment ?
• Switch to another class-Ustekinumab?
40
Masterclass
Answer Prof.Roblin
• Parenteral nutrition mandatory !!!plus switch to
Ustekinumab
41
Masterclass
CASE 2
Ioannis Kapoglou
42
Masterclass
Patient: Mr. W.L. 21 yo
Indeterminate Colitis Diagnosed 3/14
• Colonoscopy at diagnosis:
- proctosigmoiditis and erosions at ileoceacal valve and term. Ileum, Calprotectin: >1`800 mg/kg
- mesalazin oral (3g) and local with inadequate response
• Sigmoidoscopy 6 months later:
- moderate left sided colitis
- Hb 8,3 g/l
- addition of foam budesonide (not well tolerated)
Induction with systemic steroids
• Despite therapy escalation persistent symptoms
43
Masterclass
02.02.2015 follow up visit
• 3-4 bowel movements per day occasionaly with blood
• MR-enteroclysis 14.01.2015: wall thickened Sigma (20
cm), otherwise normal
• Osteodensitometry 02.02.2015: normal
44
Masterclass
Question 1
• How to proceed?
• AZA?
• Anti-TNF?
• Vedolizumab?
• Combination?
• Watch and wait?
45
Masterclass
Answer
• Both options available:
• Anti-TNF alone
• Anti-TNF with Immunomodulator
46
Masterclass
02.06.15 follow up
• After induction with IFX and under prednison 10mg 1-0-0,
Mesalazine 500 mg 2-2-2 fewer symptoms
• Decision to taper prednisone
• Calprotectin 10.07.2015: 97 mg/kg
47
Masterclass
14.07.2015 till 18.07.2015
• Hospitalization due to increasing symptoms
• 15.07.2015 rectosigmoidoscopy:
– rektosigmoiditis Mayo Score 3.
• Other causes such as C. diff, viral superinfection were
excluded
• Stool culture :Campylobacter concisus
• Adenovirus-Ag positive
48
Masterclass
Question 2: How to treat?
49
Masterclass
Question 2: How to treat?
• All measures below were justified:
50
Masterclass
Question 2: How to treat?
• All measures below were justified:
• Systemic prednison was paused
51
Masterclass
Question 2: How to treat?
• All measures below were justified:
• Systemic prednison was paused
• Budesonide foam
52
Masterclass
Question 2: How to treat?
• All measures below were justified:
• Systemic prednison was paused
• Budesonide foam
• Ciprofloxacin and metronidazol
53
Masterclass
Question 2: How to treat?
• All measures below were justified:
• Systemic prednison was paused
• Budesonide foam
• Ciprofloxacin and metronidazol
• Mesalazine was suspended
54
Masterclass
11.8.15 follow up
• Under IFX 400 mg every 8w and prednisone 10 mg 1-0-0
• 4-5 bowel movements daily, no blood
• Decision to further taper prednison
55
Masterclass
13.10.15 follow up
• 1 month after prednisone cessation
• New flare (10 bloody bowel movements daily)
• Increase steroids to 30 mg for 7 days then tapered again
• November 15: new flare prednisone to 50 mg/d
56
Masterclass
07.12.2015 follow up
• Pat. still takes 30mg prednisone
• Generally better
• More symptoms just before the next IFX-Application
• Calprotectin 824 mg/kg
57
Masterclass
Question 3: How to proceed?
• Change IFX to other anti-TNF?
• Change Class?
• Measure trough levels and Ab?
• Optimise therapy?
58
Masterclass
Answer
• Optimize Anti-TNF Therapy
• change application intervall from 8 to 4 w
59
Masterclass
Decision
60
Masterclass
Decision
• No Ab against IFX
61
Masterclass
Decision
• No Ab against IFX
• Optimise IFX every 4 w instead of every 8 w
62
Masterclass
Decision
• No Ab against IFX
• Optimise IFX every 4 w instead of every 8 w
• Try to further taper prednisone
63
Masterclass
02.02.16 follow up
• Pat. is doing better, currently under 12.5 mg prednisone
and IFX every 4 w
• Calprotectin 77,2 mg/kg
64
Masterclass
04.04.16
• Steroid dependency (<10mg/d not possible)
• IFX trough levels 0.66 ng/ml November 2015, no Ab
• Decision to increase the IFX-dosage to 600mg every 4 w
65
Masterclass
25.5.16
• Trough levels IFX:
–30.03.2016 6,53 µg/ml
–27.04.2016 14,3 µg/ml
• Still under prednisone 12,5 mg/d
– (was afraid to reduce it further)
• Pat. stable, no blood in stool
• Decision to decrease the IFX-dosis: 400mg every 4 w
66
Masterclass
13.6.16 follow up
• Stable under prednisone 12,5 mg/d and IFX 400mg every 4 w
• 09.06.16: Calprotectin 132 mg/kg
• 24.07.16: Calprotectin 99.6 mg/kg
Goal to further reduce prednisone
20.11.16 acute EBV-Infektion
67
Masterclass
30.12.16 follow up
26.12.16: Calprotectin >2400 mg/kg
Infliximab trough levels 2.08 mcg/l, no Ab
68
Masterclass
Question 4: How to proceed?
• Change anti-TNF?
• Change Class?
• Top up prednisone?
• Do a colonoscopy?
69
Masterclass
Answer
• Re-evaluation with colonoscopy justified
• Inflamatory activity control with top up of prednisone
70
Masterclass
16.01.17 colonoscopy:
• Left sided colitis with moderate activity from rectum to left
flexur
Rectum C.ascendens
71
Masterclass
21.2.17:
• Pat. is doing better
• Currently under prednisone 12,5 mg/d and IFX 400mg every 4 w
• 13.03.17: Calprotectin 113 mg/kg
• Decision to re-taper prednisone
72
Masterclass
9.5.17
• Pat. is doing fine under 5mg prednisone and IFX
73
Masterclass
Question 5?
• What to do if a new flare arises?
• Combination therapy after mononucleosis?
74
Masterclass
Answer
• Best option would be to switch class i.e. Vedolizuimab
• Cortiment could be used as bridging
75
Masterclass
CASE 6
Ioannis Linas
76
Masterclass
25 yo Male
• Ulcerative pancolitis with backwash Ileitis (02/2013)
• Montréal Classification E3
• initial manifestation 2011: elevated stool frequency, later bloody
stools
• No extraintestinal, no perianal manifestation
• Non smoker
• Negative IBD Family history
Initial Therapy (02/2013): Mesalazine, Budesonide
• No response
77
Masterclass
25 yo Male
• Ulcerative pancolitis with backwash Ileitis (02/2013)
• Montréal Classification E3
• initial manifestation 2011: elevated stool frequency, later bloody
stools
• No extraintestinal, no perianal manifestation
• Non smoker
• Negative IBD Family history
Initial Therapy (02/2013): Mesalazine, Budesonide
• No response
Steroid tapper (03/2013)
78
Masterclass
25 yo Male
• Ulcerative pancolitis with backwash Ileitis (02/2013)
• Montréal Classification E3
• initial manifestation 2011: elevated stool frequency, later bloody
stools
• No extraintestinal, no perianal manifestation
• Non smoker
• Negative IBD Family history
Initial Therapy (02/2013): Mesalazine, Budesonide
• No response
Steroid tapper (03/2013)
• No response
79
Masterclass
• 4 cycles of Infliximab
80
Masterclass
• 4 cycles of Infliximab
• No response
81
Masterclass
• 4 cycles of Infliximab
• No response
Adalimumab 09-10/2013
82
Masterclass
• 4 cycles of Infliximab
• No response
Adalimumab 09-10/2013
• No response
83
Masterclass
• 4 cycles of Infliximab
• No response
Adalimumab 09-10/2013
• No response
Patient frustrated
Alternative medicine 10/2013 – mid 2014
84
Masterclass
• 4 cycles of Infliximab
• No response
Adalimumab 09-10/2013
• No response
Patient frustrated
Alternative medicine 10/2013 – mid 2014
• No response
85
Masterclass
• 4 cycles of Infliximab
• No response
Adalimumab 09-10/2013
• No response
Patient frustrated
Alternative medicine 10/2013 – mid 2014
• No response
Colonoscopy 05/2014: Ulcerative pancolitis with backwash Ileitis
86
Masterclass
• Steroid induction + Azathioprine maintenance therapy
87
Masterclass
• Steroid induction + Azathioprine maintenance therapy
• No response
88
Masterclass
• Steroid induction + Azathioprine maintenance therapy
• No response
Golimumab 05/2015
89
Masterclass
• Steroid induction + Azathioprine maintenance therapy
• No response
Golimumab 05/2015
• Subjectively partial response
• No blood, no abdominal pain, no arthralgia
90
Masterclass
• Steroid induction + Azathioprine maintenance therapy
• No response
Golimumab 05/2015
• Subjectively partial response
• No blood, no abdominal pain, no arthralgia
But…
• Persistent diarrhea > 5-6x/d, stool urgency
• Under golimumab intermittent gingival bleeding
• Calprotectin > 1800mg/Kg
91
Masterclass
• Steroid induction + Azathioprine maintenance therapy
• No response
Golimumab 05/2015
• Subjectively partial response
• No blood, no abdominal pain, no arthralgia
But…
• Persistent diarrhea > 5-6x/d, stool urgency
• Under golimumab intermittent gingival bleeding
• Calprotectin > 1800mg/Kg
07/2015 Golimumab every 3 weeks and referral to us
92
Masterclass
Work up
• Partial clinical response, 5-6x/d diarrhea good condition
• Calprotectin > 1800 mg/Kg, CRP<3 mg/L, WBC: 4.6 G/L,
• Negative stool microbiology, parasites
• No extraintestinal manifestation
• Colonoscopy: ulcerative pancolitis with sparse ulcera but
spontaneous mucosal bleeding and backwash Ileitis.
• Mayo 3, maximal manifestation in rectum.
93
Masterclass
Histopathology:
• Chronic ulcerative pancolitis
• Minimal signs of inflammatory activity
• No CMV (IHC / PCR)
94
Masterclass
Question 1: What would you do next?
• Other anti-TNF?
• Combination therapy?
• Anti-integrin?
• Calcineurin inhibitors?
Answer Prof Roblin: In this case I would avoid trying yet another new
therapy since we do not know how well the options up to now where uset
and optimized. If you would like to change class anyway vedolizumab could
be an option
95
Masterclass
Question 1: What would you do next?
• Other anti-TNF?
• Combination therapy?
• Anti-integrin?
• Calcineurin inhibitors?
Answer Prof Roblin: In this case I would avoid trying yet another new
therapy since we do not know how well the options up to now where uset
and optimized. If you would like to change class anyway vedolizumab could
be an option
96
MasterclassOur decision:
• Combination golimumab + azathioprine
• Local therapy with alternating budesonide and
mesalazine for stool urgency
But then……
97
Masterclass
03/10/2015
98
Masterclass
• 2x Punch biopsy, Microbiology, direct immunofluorescence
• Pemphigus vegetans type hallopeau associated with the anti-
TNF therapy
• Superinfection with S. aureus
• Azathioprine stopped by the patient,
• Local steroids, antiseptics and antibiotics
99
Masterclass
100
MasterclassQuestion 2: In your experience anti-TNF associated
with autoimmune bullous skin disease?Answer Prof Roblin: I have used anti-TNFs extensively since
the time they were introduced and never encountered this
side effect
101
Masterclass
Question 3: What do we do next?
• Calcineurin inhibitors?
• Vedolizumab?
• Ustekinumab?
• Surgery?Answer Prof. Roblin. I would probably go for Vedolizumab in
this mildly active but refractory colitis. Another option but
still experimental would be the combination of vedolizumab
with an calcineurin inhibitor for induction of remission and
then maintenance with vedolizumab
Question 2: In your experience anti-TNF associated
with autoimmune bullous skin disease?Answer Prof Roblin: I have used anti-TNFs extensively since
the time they were introduced and never encountered this
side effect
102
Masterclass
Question 3: What do we do next?
• Calcineurin inhibitors?
• Vedolizumab?
• Ustekinumab?
• Surgery?Answer Prof. Roblin. I would probably go for Vedolizumab in
this mildly active but refractory colitis. Another option but
still experimental would be the combination of vedolizumab
with an calcineurin inhibitor for induction of remission and
then maintenance with vedolizumab
Question 2: In your experience anti-TNF associated
with autoimmune bullous skin disease?Answer Prof Roblin: I have used anti-TNFs extensively since
the time they were introduced and never encountered this
side effect
103
Masterclass
104
Masterclass
Our decision: vedolizumab
105
Masterclass
Our decision: vedolizumab
Question 4: After those adverse effects would a
combination with azathioprine still be an option in the
future?
106
Masterclass
Our decision: vedolizumab
Question 4: After those adverse effects would a
combination with azathioprine still be an option in the
future?
Answer Prof. Roblin: Concerning the combination of
vedolizumab with azathioprine there are only low quality data
from a post hoc analysis that are negative. So probably that is
not the best option irrespective of side effects. However there
are many centers that do it and claim to have good results.